Global intravenous solutions market dominated by the US

The global intravenous solutions market has been forecast to increase at a compound annual growth rate (CAGR) of 12.08% over the years to 2015.

Growth within the industry looks set to be driven by the increasing cases of out-patient intravenous therapies and an increasing focus on product launches. However, the adverse effects of ketorolac trometamol could pose a challenge to the growth of this market.

Companies in this industry are primarily engaged in manufacturing substances that may be infused directly into a vein. Intravenous solutions may be used to correct electrolyte imbalances, to deliver medications, for blood transfusion or as fluid replacement.

The global intravenous solutions market is experiencing some important trends that are contributing to the growth of the market. One of the major trends is the significant increase in the number of corporate agreements.

For instance, Abu Dhabi Investment House (ADIH) (investment manager of Wellpharma Medical Solutions Inc.) teamed up with Bram S.p.A. to build an intravenous manufacturing and distribution plant in Abu Dhabi in October 2010.

Although the US market comprises almost 70% of the total world market for intravenous solutions, the market for third world and emerging nations is growing much faster and presents a tremendous opportunity for the industry.

This growth is due to the building of better and higher quality health care institutions and other health care infrastructures in areas once deemed dormant.

World market growth is driven by population increases and constant up-scaling and sophistication of health care delivery. As part of this up-scaling, intravenous infusion therapy is becoming increasingly important in overall health care treatment regimens as new developments in antibiotics and other medications used in areas such as chemotherapy, burn centres, and renal/peritoneal dialysis centres favour intravenous use and application.

Key companies dominating the global intravenous solutions market include B. Braun Melsungen AG, Baxter International Inc., Hospira Inc., and Pfizer Inc.

For more information on the global intravenous solutions market, see the latest research: Global Intravenous Solutions Market Report

Follow us on Twitter @CandMResearch